U.S . NATIONAL INSTITUTES OF HEALTH

Coronavirus vaccine from Moderna shows early signs of viral immune response

The study was primarily designed to look at the safety of the shot and showed no major warning signs in a small phase 1 trial, the company said in a statement Monday. The trial is being run with the U.S. government, and Moderna plans to continue advancing it to wider testing.